The Altius Institute for Biomedical Sciences, identified by EIN 47-2231080, is dedicated to advancing biomedical discovery through innovative technologies that illuminate cell and tissue functions. With an operating budget of $32.3 million and total revenue of $25.5 million for the 2024 filing year, the organization is focused on bridging basic biological research with clinical applications to develop novel medicines. Altius does not appear to rely on a single funder for 50% or more of its revenue, ensuring a diverse funding base to support its mission. More information can be found on their website, www.altiusinstitute.org.